Jijun Liu

Randomized phase II clinical trial of cisplatin/carboplatin and etoposide (CE) alone or in combination with nivolumab as frontline therapy for extensive-stage small cell lung cancer (ES-SCLC): ECOG-ACRIN EA5161.

Ticiana Leal, Yating Wang, Afshin Dowlati et al. · Journal of Clinical Oncology · 2020 · 131 citations

Ecog-acrin Ea5161, Immunotherapy, Maintenance Nivolumab +17

Dual‐Specificity Phosphatase 9 Protects Against Nonalcoholic Fatty Liver Disease in Mice Through ASK1 Suppression

Ping Ye, Mei Xiang, Hua Liao et al. · Hepatology · 2018 · 69 citations · Full text

miR-192-5p suppresses the progression of lung cancer bone metastasis by targeting TRIM44

Peng Zou, Menghai Zhu, Chong Lian et al. · Scientific Reports · 2019 · 68 citations · Full text

Tranexamic Acid Decreases Visible and Hidden Blood Loss Without Affecting Prethrombotic State Molecular Markers in Transforaminal Thoracic Interbody Fusion for Treatment of Thoracolumbar Fracture-Dislocation

Wentao Wang, Kun Duan, Minjie Ma et al. · Spine · 2017 · 56 citations

Dual‐Specificity Phosphatase 26 Protects Against Nonalcoholic Fatty Liver Disease in Mice Through Transforming Growth Factor Beta–Activated Kinase 1 Suppression

Ping Ye, Jijun Liu, Wuping Xu et al. · Hepatology · 2018 · 52 citations · Full text